These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13355057)

  • 1. [Experimental study of the effect of BZ 55 on normal and alloxan-treated rats; morphological changes, especially pancreatic changes].
    BELLENS R; CHRISTOPHE J; GEPTS W
    Ann Endocrinol (Paris); 1956 Jul; 17(2):278-90. PubMed ID: 13355057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study of the effect of BZ 55 on normal or alloxan-treated rats. II. Effect on blood sugar].
    BELLENS R; CHRISTOPHE J; GEPTS W
    Ann Endocrinol (Paris); 1956 Jul; 17(2):291-8. PubMed ID: 13355058
    [No Abstract]   [Full Text] [Related]  

  • 3. Ineffectiveness of sulfonylureas in alloxan diabetic rats.
    MIRSKY IA; PERISUTTI G; JINKS R
    Proc Soc Exp Biol Med; 1956 Mar; 91(3):475-7. PubMed ID: 13322970
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental study of a hypoglycaemic sulfonamide. I. Morphological, and in particular pancreatic, modifications brought about in normal rats and diabetic rats by R.P. 2 254].
    GEPTS W; CHRISTOPHE J; BELLENS R
    Ann Endocrinol (Paris); 1955; 16(6):946-55. PubMed ID: 13327455
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of N-sulfanilyl-N'-butyl urea and insulin on the blood sugar level in meta-alloxan diabetes in rabbits].
    MOHNIKE G
    Arzneimittelforschung; 1956 Jul; 6(7):388-9. PubMed ID: 13355701
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of N-sulfanilyl-N'-butyl urea on blood sugar level, and phosphate, potassium and sodium level in meta-alloxan diabetes of dogs].
    BIBERGEIL H; MOHNIKE G
    Arzneimittelforschung; 1956 Jul; 6(7):391-3. PubMed ID: 13355703
    [No Abstract]   [Full Text] [Related]  

  • 7. The toxic effect of carbutamide (BZ 55) in diabetic dogs.
    SIREK A; SIREK OV; BEST CH
    Diabetes; 1957; 6(2):151-3. PubMed ID: 13427620
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of carbutamide on the insulin content of the dog pancreas.
    ROOT MA
    Diabetes; 1957; 6(1):12-6; discussion, 19-20. PubMed ID: 13397411
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of the mechanism of the curative action which para-aminobenzene-sulfamido-isopropylthiodazole exerts on experimental diabetes mellitus induced by alloxan].
    LOUBATIERES A; BOUYARD P; DE FRUTEAU LACLOS C
    C R Hebd Seances Acad Sci; 1955 Aug; 241(5):515-6. PubMed ID: 13261338
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of nadisan (BZ 55) on blood sugar in dogs with resected pancreas].
    BECKER WH; BUDDECKE E; MULLER H
    Klin Wochenschr; 1956 Sep; 34(33-34):920-1. PubMed ID: 13368430
    [No Abstract]   [Full Text] [Related]  

  • 11. On the action of BZ-55 and D-860 in pancreatectomized dogs.
    SCHAMBYE P
    Diabetes; 1957; 6(2):146-50. PubMed ID: 13427619
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of the effect of carbutamide on glucose-6-phosphatase.
    KUETHER CA; LEE HM; MARTINEZ C; PETTINGA CW; SCOTT EG
    Diabetes; 1957; 6(1):23-5; discussion, 30-2. PubMed ID: 13397414
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetes caused by alloxan in a rabbit after ligation of pancreatic duct].
    MALANDRA B
    Rass Fisiopatol Clin Ter; 1952 May; 24(5):603-15. PubMed ID: 13014335
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of N1-sulfanilyl-N2-n-butyl carbamide on the progress of alloxan diabetes in rabbits and on the glucagon content in dogs pancreas].
    CZYZK A
    Arzneimittelforschung; 1956 Dec; 6(12):700-1. PubMed ID: 13395925
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological action of a new oral antidiabetic drug].
    PELLEGRINI R
    Boll Soc Ital Biol Sper; 1956; 32(1-2):67-9. PubMed ID: 13374024
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic and pancreatic effects of polyenoylphosphatidylcholine in rats with alloxan-induced diabetes.
    Buko V; Lukivskaya O; Nikitin V; Tarasov Y; Zavodnik L; Borodinsky A; Gorenshtein B; Janz B; Gundermann KJ; Schumacher R
    Cell Biochem Funct; 1996 Jun; 14(2):131-7. PubMed ID: 8640953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of BZ 55].
    BAQUET R
    Maroc Med; 1956 Jul; 35(374):731-3. PubMed ID: 13368691
    [No Abstract]   [Full Text] [Related]  

  • 18. [New observations regarding the use of BZ 55 in the treatment of diabetes].
    Baquet R
    Maroc Med; 1957 Mar; 36(382):271-3. PubMed ID: 13429949
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanism of action of BZ 55 in human diabetes].
    BASTENIE PA; CONARD V; DE MEUTTER R; FRANCKSON JR
    Bull Mem Soc Med Hop Paris; 1956; 72(26):799-806. PubMed ID: 13383374
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)].
    BERTRAM F
    Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.